Literature DB >> 10865824

The extracellular matrix dynamically regulates smooth muscle cell responsiveness to PDGF.

E W Raines1, H Koyama, N O Carragher.   

Abstract

Focal accumulation of smooth muscle (SMC) within the arterial intima contributes to the formation of lesions of atherosclerosis. Platelet-derived growth factor (PDGF) is a potent stimulant of SMC migration and proliferation in culture that may play a role in the accumulation of SMC in atherogenesis. SMCs normally reside in the media of the artery wall surrounded by extracellular matrix (ECM), including type I collagen. In atherogenesis, the ECM is degraded, new ECM components, such as fibronectin, are synthesized and assembled, and these alterations in ECM components are associated with changes in SMC phenotype. To model the changes in ECM in normal and diseased arteries, we have analyzed SMCs cultured on different forms of type I collagen. Our studies demonstrate that integrin-mediated signals from various forms of type I collagen lead to specific and rapid modulation of the integrin signaling complex, including cytoskeletal connections, and of the responsiveness of SMC to PDGF stimulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10865824     DOI: 10.1111/j.1749-6632.2000.tb06299.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  29 in total

Review 1.  Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering.

Authors:  Jeffrey A Beamish; Ping He; Kandice Kottke-Marchant; Roger E Marchant
Journal:  Tissue Eng Part B Rev       Date:  2010-10       Impact factor: 6.389

2.  Can the DNA damage response be harnessed to modulate atherosclerotic plaque phenotype?

Authors:  Babak Razani; Elaine W Raines
Journal:  Circ Res       Date:  2015-02-27       Impact factor: 17.367

Review 3.  Oxidative depolymerization of polysaccharides by reactive oxygen/nitrogen species.

Authors:  Jinyou Duan; Dennis L Kasper
Journal:  Glycobiology       Date:  2010-10-28       Impact factor: 4.313

4.  Regulation and characteristics of vascular smooth muscle cell phenotypic diversity.

Authors:  S S M Rensen; P A F M Doevendans; G J J M van Eys
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

5.  Absence of gravin-mediated signaling inhibits development of high-fat diet-induced hyperlipidemia and atherosclerosis.

Authors:  Qiying Fan; Xing Yin; Abeer Rababa'h; Andrea Diaz Diaz; Cori S Wijaya; Sonal Singh; Santosh V Suryavanshi; Henry Hiep Vo; Moawiz Saeed; Yang Zhang; Bradley K McConnell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-08-23       Impact factor: 4.733

Review 6.  The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease.

Authors:  E W Raines
Journal:  Int J Exp Pathol       Date:  2000-06       Impact factor: 1.925

7.  Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells.

Authors:  Kristen A Johnson; Monika Polewski; Robert A Terkeltaub
Journal:  Circ Res       Date:  2008-01-17       Impact factor: 17.367

8.  Regulation of platelet-derived growth factor receptor function by integrin-associated cell surface transglutaminase.

Authors:  Evgeny A Zemskov; Elena Loukinova; Irina Mikhailenko; Richard A Coleman; Dudley K Strickland; Alexey M Belkin
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

9.  Extracellular matrix differentiating good flow versus bad flow.

Authors:  John Y-J Shyy
Journal:  Circ Res       Date:  2009-04-24       Impact factor: 17.367

10.  Aegyptin, a novel mosquito salivary gland protein, specifically binds to collagen and prevents its interaction with platelet glycoprotein VI, integrin alpha2beta1, and von Willebrand factor.

Authors:  Eric Calvo; Fuyuki Tokumasu; Osvaldo Marinotti; Jean-Luc Villeval; José M C Ribeiro; Ivo M B Francischetti
Journal:  J Biol Chem       Date:  2007-07-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.